Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 103
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Mol Immunol ; 18(6): 1545-1561, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-32457406

RESUMO

Monoclonal antibodies (mAbs) are widely utilized as therapeutic drugs for various diseases, such as cancer, autoimmune diseases, and infectious diseases. Using the avian-derived B cell line DT40, we previously developed an antibody display technology, namely, the ADLib system, which rapidly generates antigen-specific mAbs. Here, we report the development of a human version of the ADLib system and showcase the streamlined generation and optimization of functional human mAbs. Tailored libraries were first constructed by replacing endogenous immunoglobulin genes with designed human counterparts. From these libraries, clones producing full-length human IgGs against distinct antigens can be isolated, as exemplified by the selection of antagonistic mAbs. Taking advantage of avian biology, effective affinity maturation was achieved in a straightforward manner by seamless diversification of the parental clones into secondary libraries followed by single-cell sorting, quickly affording mAbs with improved affinities and functionalities. Collectively, we demonstrate that the human ADLib system could serve as an integrative platform with unique diversity for rapid de novo generation and optimization of therapeutic or diagnostic antibody leads. Furthermore, our results suggest that libraries can be constructed by introducing exogenous genes into DT40 cells, indicating that the ADLib system has the potential to be applied for the rapid and effective directed evolution and optimization of proteins in various fields beyond biomedicine.


Assuntos
Anticorpos/metabolismo , Formação de Anticorpos , Linfócitos B/metabolismo , Sequência de Aminoácidos , Animais , Anticorpos/química , Anticorpos/genética , Anticorpos Monoclonais/imunologia , Anticorpos Neutralizantes/metabolismo , Formação de Anticorpos/efeitos dos fármacos , Linfócitos B/efeitos dos fármacos , Sequência de Bases , Linhagem Celular , Galinhas , Conversão Gênica/efeitos dos fármacos , Dosagem de Genes , Variação Genética , Humanos , Ácidos Hidroxâmicos/farmacologia , Pseudogenes , Fator de Necrose Tumoral alfa/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo
2.
Nucleic Acids Res ; 43(14): 6902-18, 2015 Aug 18.
Artigo em Inglês | MEDLINE | ID: mdl-26019181

RESUMO

Efficient repair of chromosomal double-strand breaks (DSBs) by homologous recombination relies on the formation of a Rad51 recombinase filament that forms on single-stranded DNA (ssDNA) created at DSB ends. This filament facilitates the search for a homologous donor sequence and promotes strand invasion. Recently caffeine treatment has been shown to prevent gene targeting in mammalian cells by increasing non-productive Rad51 interactions between the DSB and random regions of the genome. Here we show that caffeine treatment prevents gene conversion in yeast, independently of its inhibition of the Mec1(ATR)/Tel1(ATM)-dependent DNA damage response or caffeine's inhibition of 5' to 3' resection of DSB ends. Caffeine treatment results in a dosage-dependent eviction of Rad51 from ssDNA. Gene conversion is impaired even at low concentrations of caffeine, where there is no discernible dismantling of the Rad51 filament. Loss of the Rad51 filament integrity is independent of Srs2's Rad51 filament dismantling activity or Rad51's ATPase activity and does not depend on non-specific Rad51 binding to undamaged double-stranded DNA. Caffeine treatment had similar effects on irradiated HeLa cells, promoting loss of previously assembled Rad51 foci. We conclude that caffeine treatment can disrupt gene conversion by disrupting Rad51 filaments.


Assuntos
Cafeína/farmacologia , DNA de Cadeia Simples/metabolismo , Conversão Gênica/efeitos dos fármacos , Rad51 Recombinase/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Células HeLa , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/antagonistas & inibidores , Biossíntese de Proteínas , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/antagonistas & inibidores
3.
J Photochem Photobiol B ; 144: 76-84, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25728226

RESUMO

Fluoroquinolones are widely used anti-bacterial agents that are known to exhibit moderate to severe phototoxicity. Furthermore some of them reveal photogenotoxicity under UV irradiation. Incidence of side effects due to light exposure may be augmented, if the medicament is used topically. The main goal of this work was to compare the extent of photodegradation of ofloxacin in ointments with various excipients: hydrated or non-hydrated base and the addition of sunscreens: bisoctrizole (Tinosorb M) and bemotrizinol (Tinosorb S). The next goal of present work was the analysis of phototoxicity and photogenotoxicity of ofloxacin photodegradation products in tested ointments and in solutions with the umu-test, the test of mitotic gene conversion with Saccharomyces cerevisiae D7 and the micronucleus assay with V79 Chinese hamster cell line. At the same time an attempt was made to determinate the photodegradation products of ofloxacin in different unguents variants. We observed a significant photoprotective effect in ointment with Tinosorb M. We did not evaluated relevant differences regarding the genotoxicity and toxicity of unguents. However, the pre-irradiated ofloxacin solutions in comparison to samples stored in the dark were significantly more genotoxic to bacteria, slightly increased the number of micronuclei in V79 cell line and were toxic to the yeast strain.


Assuntos
Ofloxacino/química , Ofloxacino/toxicidade , Pomadas/química , Fotólise , Protetores Solares/química , Raios Ultravioleta , Animais , Linhagem Celular , Cricetulus , Conversão Gênica/efeitos dos fármacos , Conversão Gênica/efeitos da radiação , Testes para Micronúcleos , Mutagênicos/química , Mutagênicos/toxicidade , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/efeitos da radiação , Soluções , Água/química
4.
Methods Mol Biol ; 823: 107-18, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22081342

RESUMO

New technologies allow for genome-scale measurement of DNA methylation. In an effort to increase the clinical utility of DNA methylation as a biomarker, we have adapted a commercial bisulfite epigenotyping assay for genome-wide methylation profiling in archival formalin-fixed paraffin-embedded pathology specimens. This chapter takes the reader step by step through a biomarker discovery experiment to identify phenotype-correlated DNA methylation signatures in routine pathology specimens.


Assuntos
Metilação de DNA , Epigenômica/métodos , Genoma Humano , Conversão Gênica/efeitos dos fármacos , Humanos , Mutagênese/efeitos dos fármacos , Inclusão em Parafina , Sulfatos/efeitos adversos , Fixação de Tecidos
5.
J Environ Pathol Toxicol Oncol ; 30(3): 189-97, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22126612

RESUMO

The modifying effect of butylated hydroxytoluene (BHT) on 60Co gamma radiation and 4-nitro-quinoline 1-oxide-induced gene conversion and back mutation frequencies was investigated using diploid yeast Saccharomyces cerevisiae D7. Cells were exposed to 100 or 400 Gy in the presence of 0.025-0.25 mM BHT. BHT exhibited radioprotection and significantly reduced radiation-induced gene conversion and back mutation frequencies as well as cell killing. In another set of experiments, cells were simultaneously treated with 0.025-0.1 mM BHT and 0.5 µM 4-NQO. BHT significantly enhanced 4-NQO-induced gene conversion and back mutation frequencies. BHT post-treatment did not modify radiation-induced genetic events but enhanced 4-NQO-induced back mutation frequencies, indicating its potential to act as a tumor-promoting agent with 4-NQO.


Assuntos
4-Nitroquinolina-1-Óxido/farmacologia , Hidroxitolueno Butilado/farmacologia , Aditivos Alimentares/farmacologia , Raios gama/efeitos adversos , Saccharomyces cerevisiae/genética , Células Cultivadas , Dimetil Sulfóxido/farmacologia , Sequestradores de Radicais Livres/farmacologia , Conversão Gênica/efeitos dos fármacos , Modelos Biológicos , Mutagênicos/farmacologia , Taxa de Mutação , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos da radiação
6.
PLoS Genet ; 7(7): e1002148, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21779174

RESUMO

RAD51 recombinase polymerizes at the site of double-strand breaks (DSBs) where it performs DSB repair. The loss of RAD51 causes extensive chromosomal breaks, leading to apoptosis. The polymerization of RAD51 is regulated by a number of RAD51 mediators, such as BRCA1, BRCA2, RAD52, SFR1, SWS1, and the five RAD51 paralogs, including XRCC3. We here show that brca2-null mutant cells were able to proliferate, indicating that RAD51 can perform DSB repair in the absence of BRCA2. We disrupted the BRCA1, RAD52, SFR1, SWS1, and XRCC3 genes in the brca2-null cells. All the resulting double-mutant cells displayed a phenotype that was very similar to that of the brca2-null cells. We suggest that BRCA2 might thus serve as a platform to recruit various RAD51 mediators at the appropriate position at the DNA-damage site.


Assuntos
Proteína BRCA2/genética , Epistasia Genética , Recombinação Homóloga , Rad51 Recombinase/genética , Animais , Camptotecina/farmacologia , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/efeitos da radiação , Galinhas , Aberrações Cromossômicas/efeitos dos fármacos , Aberrações Cromossômicas/efeitos da radiação , Cisplatino/farmacologia , Células Clonais , Dano ao DNA , Epistasia Genética/efeitos dos fármacos , Epistasia Genética/efeitos da radiação , Raios gama , Conversão Gênica/efeitos dos fármacos , Conversão Gênica/efeitos da radiação , Deleção de Genes , Loci Gênicos/genética , Genoma/genética , Recombinação Homóloga/efeitos dos fármacos , Recombinação Homóloga/efeitos da radiação , Modelos Biológicos , Fenótipo , Ftalazinas/farmacologia , Piperazinas/farmacologia , Rad51 Recombinase/deficiência
7.
Environ Mol Mutagen ; 52(2): 130-44, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20839230

RESUMO

Interactions between bleomycin (BLM) and conventional or unconventional intercalating agents were analyzed in an assay for mitotic gene conversion at the trp5 locus and reversion of the ilv1-92 allele in Saccharomyces cerevisiae strain D7. BLM is a potent recombinagen and mutagen in the assay. Various chemicals modulate the genetic activity of BLM, producing either antimutagenic effects or enhanced genotoxicity. Effects of cationic amino compounds include enhancement of BLM activity by aminoacridines and protection against BLM by aliphatic amines. The potentiation of BLM is similar to findings in a micronucleus-based BLM amplification assay in Chinese hamster V79 cells. In this study, the amplification of BLM activity was explored in yeast using known intercalators, compounds structurally related to known intercalators, and unconventional intercalators that were identified on the basis of computer modeling or results in the Chinese hamster BLM amplification assay. As shown in previous studies, the classical intercalator 9-aminoacridine (9AA) caused dose-dependent enhancement of BLM activity. Other compounds found to enhance the induction of mitotic recombination and point mutations in strain D7 were chlorpromazine, chloroquine, mefloquine, tamoxifen, diphenhydramine, benzophenone, and 3-hydroxybenzophenone. The increased activity was detectable by cotreatment of yeast with BLM and the modulator compound in growth medium or by separate interaction of the intercalator with DNA followed by BLM treatment of nongrowing cells in buffer. The data support the interpretation drawn from micronucleus assays in mammalian cells that BLM enhancement results from DNA intercalation and may be useful in detecting noncovalent interactions with DNA. Environ.


Assuntos
Bleomicina/farmacologia , Substâncias Intercalantes/farmacologia , Mutagênicos/farmacologia , Recombinação Genética/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos dos fármacos , Aminas/farmacologia , Animais , Benzofenonas/farmacologia , Linhagem Celular , Cloroquina/farmacologia , Clorpromazina/farmacologia , Cricetinae , Dano ao DNA , Sinergismo Farmacológico , Conversão Gênica/efeitos dos fármacos , Mefloquina/farmacologia , Testes de Mutagenicidade , Saccharomyces cerevisiae/genética , Tamoxifeno/farmacologia
8.
PLoS Biol ; 8(7): e1000428, 2010 Jul 20.
Artigo em Inglês | MEDLINE | ID: mdl-20652015

RESUMO

Genetic variation at immunoglobulin (Ig) gene variable regions in B-cells is created through a multi-step process involving deamination of cytosine bases by activation-induced cytidine deaminase (AID) and their subsequent mutagenic repair. To protect the genome from dangerous, potentially oncogenic effects of off-target mutations, both AID activity and mutagenic repair are targeted specifically to the Ig genes. However, the mechanisms of targeting are unknown and recent data have highlighted the role of regulating mutagenic repair to limit the accumulation of somatic mutations resulting from the more widely distributed AID-induced lesions to the Ig genes. Here we investigated the role of the DNA damage sensor poly-(ADPribose)-polymerase-1 (PARP-1) in the repair of AID-induced DNA lesions. We show through sequencing of the diversifying Ig genes in PARP-1(-/-) DT40 B-cells that PARP-1 deficiency results in a marked reduction in gene conversion events and enhanced high-fidelity repair of AID-induced lesions at both Ig heavy and light chains. To further characterize the role of PARP-1 in the mutagenic repair of AID-induced lesions, we performed functional analyses comparing the role of engineered PARP-1 variants in high-fidelity repair of DNA damage induced by methyl methane sulfonate (MMS) and the mutagenic repair of lesions at the Ig genes induced by AID. This revealed a requirement for the previously uncharacterized BRCT domain of PARP-1 to reconstitute both gene conversion and a normal rate of somatic mutation at Ig genes, while being dispensable for the high-fidelity base excision repair. From these data we conclude that the BRCT domain of PARP-1 is required to initiate a significant proportion of the mutagenic repair specific to diversifying antibody genes. This role is distinct from the known roles of PARP-1 in high-fidelity DNA repair, suggesting that the PARP-1 BRCT domain has a specialized role in assembling mutagenic DNA repair complexes involved in antibody diversification.


Assuntos
Conversão Gênica/genética , Genes de Imunoglobulinas/genética , Poli(ADP-Ribose) Polimerases/química , Poli(ADP-Ribose) Polimerases/metabolismo , Animais , Sobrevivência Celular/efeitos dos fármacos , Galinhas , Citidina Desaminase/metabolismo , Quebras de DNA de Cadeia Dupla/efeitos dos fármacos , Reparo do DNA/efeitos dos fármacos , Ativação Enzimática/efeitos dos fármacos , Conversão Gênica/efeitos dos fármacos , Técnicas de Inativação de Genes , Inibidores de Histona Desacetilases/farmacologia , Humanos , Ácidos Hidroxâmicos/farmacologia , Modelos Biológicos , Proteínas Mutantes/metabolismo , Mutação/genética , Poli(ADP-Ribose) Polimerases/deficiência , Estrutura Terciária de Proteína , Recombinação Genética/efeitos dos fármacos , Recombinação Genética/genética , Hipermutação Somática de Imunoglobulina/efeitos dos fármacos
9.
Eukaryot Cell ; 9(7): 1049-63, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20435698

RESUMO

We characterized the calcineurin (CaN) gene family, including the subunits CaNA and CaNB, based upon sequence information obtained from the Paramecium genome project. Paramecium tetraurelia has seven subfamilies of the catalytic CaNA subunit and one subfamily of the regulatory CaNB subunit, with each subfamily having two members of considerable identity on the amino acid level (>or=55% between subfamilies, >or=94% within CaNA subfamilies, and full identity in the CaNB subfamily). Within CaNA subfamily members, the catalytic domain and the CaNB binding region are highly conserved and molecular modeling revealed a three-dimensional structure almost identical to a human ortholog. At 14 members, the size of the CaNA family is unprecedented, and we hypothesized that the different CaNA subfamily members were not strictly redundant and that at least some fulfill different roles in the cell. This was tested by selecting two phylogenetically distinct members of this large family for posttranscriptional silencing by RNA interference. The two targets resulted in differing effects in exocytosis, calcium dynamics, and backward swimming behavior that supported our hypothesis that the large, highly conserved CaNA family members are not strictly redundant and that at least two members have evolved diverse but overlapping functions. In sum, the occurrence of CaN in Paramecium spp., although disputed in the past, has been established on a molecular level. Its role in exocytosis and ciliary beat regulation in a protozoan, as well as in more complex organisms, suggests that these roles for CaN were acquired early in the evolution of this protein family.


Assuntos
Calcineurina/metabolismo , Cálcio/metabolismo , Domínio Catalítico , Família Multigênica , Paramecium tetraurellia/enzimologia , Proteínas de Protozoários/metabolismo , Calcineurina/genética , Sinalização do Cálcio/efeitos dos fármacos , Exocitose/efeitos dos fármacos , Conversão Gênica/efeitos dos fármacos , Genes de Protozoários , Íntrons/genética , Modelos Biológicos , Movimento/efeitos dos fármacos , Mutação/genética , Paramecium tetraurellia/citologia , Paramecium tetraurellia/efeitos dos fármacos , Paramecium tetraurellia/genética , Filogenia , Cloreto de Potássio/farmacologia , Estrutura Terciária de Proteína , Proteínas de Protozoários/química , Proteínas de Protozoários/genética , Interferência de RNA/efeitos dos fármacos , Homologia de Sequência de Aminoácidos , Soluções
10.
Mutagenesis ; 24(4): 317-29, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19406902

RESUMO

Strain D7 of Saccharomyces cerevisiae was used to measure the induction by bleomycin (BLM) of mitotic recombination at the trp5 locus and point mutations at ilv1 in the presence and absence of acridine compounds. BLM is a potent mutagen and recombinagen in the D7 assay. The acridines vary, some being mutagenic or recombinagenic and others not. Combined treatments were used to distinguish whether a genetically inactive acridine has no effect on the genetic activity of BLM or modulates its action. When an acridine is itself genetically active, combined treatments were used to determine whether its effects are additive with those of BLM or whether there is interaction between the two compounds. Acridine compounds that share the ability to intercalate between the base pairs of DNA but differ in their mutagenic specificity owing to the presence of different substituent groups were analysed. Clear potentiation and synergistic interactions were detected in combined treatments with BLM and aminoacridines, nitroacridines or an acridine mustard. Potentiation and synergy were also observed in sequential exposures in which the yeast were grown in the presence of acridine compounds and then treated with BLM in the absence of free acridine. The results are consistent with an increase in BLM susceptibility conferred by acridine intercalation. It is likely that the intercalating agents increase the access of BLM to the minor groove of DNA, where it abstracts a hydrogen from the 4' position of deoxyribose, creating a free radical that is processed into strand breaks.


Assuntos
Acridinas/farmacologia , Bleomicina/farmacologia , Mutagênicos , Recombinação Genética , Saccharomyces cerevisiae/efeitos dos fármacos , Alelos , Antibióticos Antineoplásicos/farmacologia , DNA Fúngico/química , DNA Fúngico/genética , Radicais Livres , Conversão Gênica/efeitos dos fármacos , Genes Fúngicos/efeitos dos fármacos , Modelos Químicos , Testes de Mutagenicidade , Mutação Puntual , Saccharomyces cerevisiae/metabolismo
11.
DNA Repair (Amst) ; 7(10): 1624-35, 2008 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-18603020

RESUMO

Thymidylate deprivation brings about "thymineless death" in prokaryotes and eukaryotes. Although the precise mechanism for thymineless death has remained elusive, inhibition of the enzyme thymidylate synthase (TS), which catalyzes the de novo synthesis of TMP, has served for many years as a basis for chemotherapeutic strategies. Numerous studies have identified a variety of cellular responses to thymidylate deprivation, including disruption of DNA replication and induction of DNA breaks. Since stalled or collapsed replication forks and strand breaks are generally viewed as being recombinogenic, it is not surprising that a link has been demonstrated between recombination induction and thymidylate deprivation in bacteria and lower eukaryotes. A similar connection between recombination and TS inhibition has been suggested by studies done in mammalian cells, but the relationship between recombination and TS inhibition in mammalian cells had not been demonstrated rigorously. To gain insight into the mechanism of thymineless death in mammalian cells, in this work we undertook a direct investigation of recombination in human cells treated with raltitrexed (RTX), a folate analog that is a specific inhibitor of TS. Using a model system to study intrachromosomal homologous recombination in cultured fibroblasts, we provide definitive evidence that treatment with RTX can stimulate accurate recombination events in human cells. Gene conversions not associated with crossovers were specifically enhanced several-fold by RTX. Additional experiments demonstrated that recombination events provoked by a double-strand break (DSB) were not impacted by treatment with RTX, nor was error-prone DSB repair via nonhomologous end-joining. Our work provides evidence that thymineless death in human cells is not mediated by corruption of DSB repair processes and suggests that an increase in chromosomal recombination may be an important element of cellular responses leading to thymineless death.


Assuntos
Cromossomos Humanos/metabolismo , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Antagonistas do Ácido Fólico/farmacologia , Quinazolinas/farmacologia , Recombinação Genética/efeitos dos fármacos , Tiofenos/farmacologia , Timidilato Sintase/antagonistas & inibidores , Sequência de Bases , Southern Blotting , Linhagem Celular , Cromossomos Humanos/enzimologia , Troca Genética/efeitos dos fármacos , Quebras de DNA de Cadeia Dupla/efeitos dos fármacos , Fibroblastos/enzimologia , Conversão Gênica/efeitos dos fármacos , Humanos , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Especificidade por Substrato/efeitos dos fármacos , Timidilato Sintase/genética
12.
Genes Cells ; 13(3): 255-68, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18298800

RESUMO

Modifications of histones are reportedly associated with the regulation of immunoglobulin (Ig) gene diversification mechanisms, but the extent of their involvement in promoting sequence alterations at the Ig variable (V) regions still remains to be elucidated. We have previously demonstrated that Ig gene conversion in the B cell line DT40 is accompanied by the local hyperacetylation of histones, and that its frequency is highly increased in cells treated with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA). In this report, we describe the enhancing effects of the homozygous deletion of HDAC2 (HDAC2-/-) on Ig gene conversion. Remarkably, sequence analysis revealed that the distribution of the gene conversion tracts induced throughout the Ig V regions in HDAC2-/- was significantly different from the diversification patterns in TSA-treated wild-type cultures. Furthermore, we found that the effects of HDAC2-/- and of the treatment with TSA were additive as regards histone acetylation, Ig gene transcription, gene conversion frequency and distribution of gene conversion tracts. These results underscore the potential participation of HDAC-mediated histone acetylation in Ig diversification, but also suggest a specific role of HDAC2 to control the spatial targeting of Ig gene conversion.


Assuntos
Linfócitos B/metabolismo , Conversão Gênica/genética , Genes de Imunoglobulinas/genética , Histona Desacetilases/genética , Proteínas Repressoras/genética , Acetilação/efeitos dos fármacos , Animais , Linfócitos B/efeitos dos fármacos , Células Cultivadas , Galinhas , Relação Dose-Resposta a Droga , Conversão Gênica/efeitos dos fármacos , Deleção de Genes , Genes de Imunoglobulinas/efeitos dos fármacos , Histona Desacetilase 2 , Inibidores de Histona Desacetilases , Histona Desacetilases/deficiência , Histonas/efeitos dos fármacos , Histonas/metabolismo , Homozigoto , Ácidos Hidroxâmicos/farmacologia , Região Variável de Imunoglobulina/genética , Proteínas Repressoras/antagonistas & inibidores , Reprodutibilidade dos Testes , Análise de Sequência de DNA , Transcrição Gênica/efeitos dos fármacos
13.
Genetics ; 178(1): 113-26, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18202362

RESUMO

Rad51 requires a number of other proteins, including the Rad51 paralogs, for efficient recombination in vivo. Current evidence suggests that the yeast Rad51 paralogs, Rad55 and Rad57, are important in formation or stabilization of the Rad51 nucleoprotein filament. To gain further insights into the function of the Rad51 paralogs, reporters were designed to measure spontaneous or double-strand break (DSB)-induced sister or nonsister recombination. Spontaneous sister chromatid recombination (SCR) was reduced 6000-fold in the rad57 mutant, significantly more than in the rad51 mutant. Although the DSB-induced recombination defect of rad57 was suppressed by overexpression of Rad51, elevated temperature, or expression of both mating-type alleles, the rad57 defect in spontaneous SCR was not strongly suppressed by these same factors. In addition, the UV sensitivity of the rad57 mutant was not strongly suppressed by MAT heterozygosity, even though Rad51 foci were restored under these conditions. This lack of suppression suggests that Rad55 and Rad57 have different roles in the recombinational repair of stalled replication forks compared with DSB repair. Furthermore, these data suggest that most spontaneous SCR initiates from single-stranded gaps formed at stalled replication forks rather than DSBs.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Rad51 Recombinase/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/enzimologia , Saccharomyces cerevisiae/genética , Homologia de Sequência de Aminoácidos , Troca de Cromátide Irmã/genética , Adenosina Trifosfatases , Quebras de DNA de Cadeia Dupla/efeitos dos fármacos , Quebras de DNA de Cadeia Dupla/efeitos da radiação , Quebras de DNA de Cadeia Simples/efeitos dos fármacos , Quebras de DNA de Cadeia Simples/efeitos da radiação , Enzimas Reparadoras do DNA , Diploide , Conversão Gênica/efeitos dos fármacos , Conversão Gênica/efeitos da radiação , Heterozigoto , Fator de Acasalamento , Modelos Genéticos , Mutagênicos/farmacologia , Mutação/efeitos dos fármacos , Peptídeos/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Sequências Repetitivas de Ácido Nucleico/genética , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos da radiação , Troca de Cromátide Irmã/efeitos dos fármacos , Troca de Cromátide Irmã/efeitos da radiação , Supressão Genética/efeitos dos fármacos , Supressão Genética/efeitos da radiação , Temperatura , Raios Ultravioleta
14.
Eukaryot Cell ; 6(10): 1889-904, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17693596

RESUMO

TAC1 (for transcriptional activator of CDR genes) is critical for the upregulation of the ABC transporters CDR1 and CDR2, which mediate azole resistance in Candida albicans. While a wild-type TAC1 allele drives high expression of CDR1/2 in response to inducers, we showed previously that TAC1 can be hyperactive by a gain-of-function (GOF) point mutation responsible for constitutive high expression of CDR1/2. High azole resistance levels are achieved when C. albicans carries hyperactive alleles only as a consequence of loss of heterozygosity (LOH) at the TAC1 locus on chromosome 5 (Chr 5), which is linked to the mating-type-like (MTL) locus. Both are located on the Chr 5 left arm along with ERG11 (target of azoles). In this work, five groups of related isolates containing azole-susceptible and -resistant strains were analyzed for the TAC1 and ERG11 alleles and for Chr 5 alterations. While recovered ERG11 alleles contained known mutations, 17 new TAC1 alleles were isolated, including 7 hyperactive alleles with five separate new GOF mutations. Single-nucleotide-polymorphism analysis of Chr 5 revealed that azole-resistant strains acquired TAC1 hyperactive alleles and, in most cases, ERG11 mutant alleles by LOH events not systematically including the MTL locus. TAC1 LOH resulted from mitotic recombination of the left arm of Chr 5, gene conversion within the TAC1 locus, or the loss and reduplication of the entire Chr 5. In one case, two independent TAC1 hyperactive alleles were acquired. Comparative genome hybridization and karyotype analysis revealed the presence of isochromosome 5L [i(5L)] in two azole-resistant strains. i(5L) leads to increased copy numbers of azole resistance genes present on the left arm of Chr 5, among them TAC1 and ERG11. Our work shows that azole resistance was due not only to the presence of specific mutations in azole resistance genes (at least ERG11 and TAC1) but also to their increase in copy number by LOH and to the addition of extra Chr 5 copies. With the combination of these different modifications, sophisticated genotypes were obtained. The development of azole resistance in C. albicans is therefore a powerful instrument for generating genetic diversity.


Assuntos
Azóis/farmacologia , Candida albicans/efeitos dos fármacos , Candida albicans/isolamento & purificação , Farmacorresistência Fúngica/efeitos dos fármacos , Evolução Molecular , Alelos , Aneuploidia , Candida albicans/citologia , Candida albicans/genética , Mapeamento Cromossômico , Cromossomos Fúngicos , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Conversão Gênica/efeitos dos fármacos , Dosagem de Genes , Duplicação Gênica/efeitos dos fármacos , Genótipo , Testes de Sensibilidade Microbiana , Mitose/efeitos dos fármacos , Mutação/genética , Hibridização de Ácido Nucleico , Polimorfismo de Nucleotídeo Único/genética , Recombinação Genética/efeitos dos fármacos
15.
Mutat Res ; 623(1-2): 41-52, 2007 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-17428504

RESUMO

The effects of amines on the induction of mitotic gene conversion by bleomycin (BLM) were studied at the trp5 locus in Saccharomyces cerevisiae strain D7. BLM induces double-strand breaks in DNA and is a potent recombinagen in this assay. The polyamine spermidine causes concentration-dependent protection against the genotoxicity of BLM, reducing the convertant frequency by over 90% under the most protective conditions. Spermine, diethylenetriamine, ethylenediamine, putrescine, and ethylamine were also antigenotoxic in combined treatments with BLM. There was a general correspondence between the protective effect and the number of amino groups, suggesting that more strongly cationic amines tend to be stronger antirecombinagens. Electrostatic association of the amines with DNA probably hinders BLM access to the 4' position of deoxyribose where it generates a free radical. Other amines interact with BLM differently from these unbranched aliphatic amines. The aminothiol cysteamine inhibits the genotoxicity of BLM under hypoxic conditions but increases it under euoxic conditions. In contrast, pargyline potentiates the genotoxicity of BLM under hypoxic conditions but not under euoxic conditions. The antirecombinagenic effect of cysteamine apparently involves DNA binding and depletion of oxygen needed for BLM activity, whereas its potentiation of BLM entails its serving as an electron source for the activation of BLM. Pargyline may enhance BLM indirectly by preventing the depletion of oxygen by monoamine and polyamine oxidase. The planar 9-aminoacridine weakly induces gene conversion in strain D7, but it is strongly synergistic with BLM. Enhancement of BLM activity by this compound and by the related nitroacridine Entozon is apparently mediated by intercalation of the acridine ring system into DNA. Thus, the influence of amines on the genotoxicity of BLM in yeast encompasses antigenotoxic, potentiating, and synergistic interactions. The underlying mechanisms involve noncovalent association with DNA, altered BLM access to DNA, and modulation of physiological conditions.


Assuntos
Bleomicina/toxicidade , DNA Fúngico/efeitos dos fármacos , Mutagênicos/toxicidade , Aminas/farmacologia , DNA Fúngico/química , DNA Fúngico/genética , Interações Medicamentosas , Conversão Gênica/efeitos dos fármacos , Genes Fúngicos/efeitos dos fármacos , Saccharomyces cerevisiae/química , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/genética
16.
Mutat Res ; 606(1-2): 27-38, 2006 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-16678471

RESUMO

Essential oils (EOs) extracted from medicinal plants such as Origanum compactum, Artemisia herba alba and Cinnamomum camphora are known for their beneficial effects in humans. The present study was undertaken to investigate their possible antigenotoxic effects in an eukaryotic cell system, the yeast Saccharomyces cerevisiae. The EOs alone showed some cytotoxicity and cytoplasmic petite mutations, i.e. mitochondrial damage, but they were unable to induce nuclear genetic events. In combination with exposures to nuclear mutagens such as 254-nm UVC radiation, 8-methoxypsoralen (8-MOP) plus UVA radiation and methylmethane sulfonate (MMS), treatments with these EOs produced a striking increase in the amount of cytoplasmic petite mutations but caused a significant reduction in revertants and mitotic gene convertants induced among survivors of the diploid tester strain D7. In a corresponding rho0 strain, the level of nuclear genetic events induced by the nuclear mutagens UVC and 8-MOP plus UVA resulted in the same reduced level as the combined treatments with the EOs. This clearly suggests a close relationship between the enhancement of cytoplasmic petites (mitochondrial damage) in the presence of the EOs and the reduction of nuclear genetic events induced by UVC or 8-MOP plus UVA. After MMS plus EO treatment, induction of these latter events was comparable at least per surviving fraction in wildtype and rho0 cells, and apparently less dependent on cytoplasmic petite induction. Combined treatments with MMS and EOs clearly triggered switching towards late apoptosis/necrosis indicating an involvement of this phenomenon in EO-induced cell killing and concomitant decreases in nuclear genetic events. After UVC and 8-MOP plus UVA plus EO treatments, little apoptosis and necrosis were observed. The antigenotoxic effects of the EOs appeared to be predominantly linked to the induction of mitochondrial dysfunction.


Assuntos
Diploide , Metoxaleno/farmacologia , Metanossulfonato de Metila/farmacologia , Óleos Voláteis/farmacologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos da radiação , Raios Ultravioleta , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Artemisia/química , Sobrevivência Celular , Cinnamomum camphora/química , Citoplasma/metabolismo , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Conversão Gênica/efeitos dos fármacos , Conversão Gênica/efeitos da radiação , Mutagênicos/farmacologia , Necrose , Origanum/química , Mutação Puntual/efeitos dos fármacos , Mutação Puntual/efeitos da radiação , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/genética
17.
Antimicrob Agents Chemother ; 50(1): 359-61, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16377711

RESUMO

A macrolide-resistant clinical isolate of Streptococcus pneumoniae with 23S rRNA mutations showed a heterogeneous phenotype and genotype. The mutant 23S rRNA genes from this isolate transformed susceptible strain R6 to resistance. Culture of resistant strain R6 in the absence of antibiotic pressure showed gene conversion to occur between the four 23S rRNA alleles, resulting in reversion to susceptibility with the resistant phenotype showing a fitness cost. These data explain the disappearance on subculture of heterogeneous macrolide resistance in the pneumococcus.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana/genética , Conversão Gênica/efeitos dos fármacos , Macrolídeos/farmacologia , RNA Ribossômico 23S/genética , Streptococcus pneumoniae/efeitos dos fármacos , Humanos , Infecções Pneumocócicas/microbiologia , RNA Bacteriano/química , RNA Bacteriano/genética , RNA Ribossômico 23S/química , Streptococcus pneumoniae/genética , Streptococcus pneumoniae/metabolismo
19.
Mol Cell ; 11(6): 1661-71, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12820977

RESUMO

Equal sister chromatid exchange (SCE) has been thought to be an important mechanism of double-strand break (DSB) repair in eukaryotes, but this has never been proven due to the difficulty of distinguishing SCE products from parental molecules. To evaluate the biological relevance of equal SCE in DSB repair and to understand the underlying molecular mechanism, we developed recombination substrates for the analysis of DSB repair by SCE in yeast. In these substrates, most breaks are limited to one chromatid, allowing the intact sister chromatid to serve as the repair template; both equal and unequal SCE can be detected. We show that equal SCE is a major mechanism of DSB repair, is Rad51 dependent, and is stimulated by Rad59 and Mre11. Our work provides a physical analysis of mitotically occurring SCE in vivo and opens new perspectives for the study and understanding of DSB repair in eukaryotes.


Assuntos
Dano ao DNA/genética , Reparo do DNA/genética , Saccharomyces cerevisiae/genética , Troca de Cromátide Irmã , Cromátides/efeitos dos fármacos , DNA Fúngico/efeitos dos fármacos , DNA Fúngico/genética , DNA Fúngico/metabolismo , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Desoxirribonucleases de Sítio Específico do Tipo II/farmacologia , Endodesoxirribonucleases/genética , Endodesoxirribonucleases/metabolismo , Exodesoxirribonucleases/genética , Exodesoxirribonucleases/metabolismo , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Conversão Gênica/efeitos dos fármacos , Cinética , Mitose/genética , Modelos Genéticos , Rad51 Recombinase , Recombinação Genética , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Especificidade por Substrato , Moldes Genéticos
20.
Mutagenesis ; 18(1): 25-36, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12473732

RESUMO

The toxicity of most drugs is associated with their enzymatic conversion to toxic metabolites. Bioactivation reactions occur in a range of cellular organs and organelles, including mitochondria. We have investigated different effects (i.e. growth inhibition, mortality and genotoxicity) of doxorubicin, epirubicin and mitoxantrone on the D7 strain of Saccharomyces cerevisiae and on its petite (rho degrees ) respiratory-deficient mutant at various cellular concentrations of cytochrome P450 and glutathione (GSH). The data confirmed the importance of oxygen production for doxorubicin toxicity. The complete absence, or a very low level, of cytochrome oxidase subunit IV conferred some resistance to doxorubicin. Low GSH levels decreased resistance to doxorubicin in both strains, suggesting that thiol depletion could potentiate membrane lipid peroxidation. Doxorubicin induction of petite colonies suggests that the drug is able to select rather than induce respiratory-deficient mutants. Epirubicin induced levels of cytotoxicity similar to those of doxorubicin. The effects did not appear to be significantly dependent on mitochondrial function or GSH levels, whereas cells were strongly protected by cytochrome P450. GSH did not induce an evident alteration. Neither were genotoxic effects induced. Mitoxantrone had reduced levels of both growth inhibition and cytotoxicity in comparison to anthracyclines and induced convertants, revertants and aberrants. All the effects considered were amplified at high cytochrome P450 cellular concentrations, although the drug was also shown to act without previous metabolism via cytochrome P450. Anthracenedione effectiveness was increased by metabolism via cytochrome P450 and partially reduced by GSH. However, further mechanisms were suggested, which might implicate mitochondrial function and/or production of electrophilic cytotoxic and/or genotoxic intermediates by means of GSH conjugation. The biological effectiveness of doxorubicin, epirubicin and mitoxantrone on S.cerevisiae was shown to be strictly dependent on cell-specific physiological/biochemical conditions, such as a functional respiratory chain and levels of cytochrome P450 and GSH.


Assuntos
Antineoplásicos/toxicidade , Doxorrubicina/toxicidade , Epirubicina/toxicidade , Mitoxantrona/toxicidade , Saccharomyces cerevisiae/efeitos dos fármacos , Antineoplásicos/metabolismo , Biotransformação , Divisão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Sistema Enzimático do Citocromo P-450/metabolismo , Grupo dos Citocromos b/análise , Grupo dos Citocromos c/análise , DNA Mitocondrial/efeitos dos fármacos , DNA Mitocondrial/genética , Doxorrubicina/metabolismo , Transporte de Elétrons , Complexo IV da Cadeia de Transporte de Elétrons/análise , Complexo IV da Cadeia de Transporte de Elétrons/genética , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Epirubicina/metabolismo , Conversão Gênica/efeitos dos fármacos , Glutationa/metabolismo , Mitoxantrona/metabolismo , Testes de Mutagenicidade , Consumo de Oxigênio/genética , Mutação Puntual/efeitos dos fármacos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/fisiologia , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...